News
Thesis With the Inflation Reduction Act providing sustained financial incentives to transition to renewable sources of energy, and the aggregate cost of photovoltaics now...
Hi, what are you looking for?
iFintechWorld
iFintechWorld
News
Veris Residential, Inc. (NYSE:VRE) Q3 2024 Earnings Conference Call October 31, 2024 8:30 AM ET Company Participants Taryn Fielder – General Counsel & SecretaryMahbod...
News
Rush Street Interactive, Inc. (NYSE:RSI) Q3 2024 Earnings Call October 30, 2024 6:00 PM ET Company Participants Richard Schwartz – Chief Executive OfficerKyle Sauers...
News
This article was written by Follow For almost a decade, I held research analyst positions in various investment firms, mostly in Toronto. In the...
News
Overview The US dollar begins the new week on a firm note. It is trading at new highs for the year against the Japanese...
News
Marketing automation company, Klaviyo, Inc. (NYSE:KVYO), earned a first-day valuation of $9.2 billion, after going public this week. Klaviyo is part of a new...
News
Thesis Exxon Mobil (NYSE:XOM) is generating massive amounts of free cash flow. They have done a lot of deleveraging over the past few years...
News
Investors are always looking to move their capital to sectors that can offer the greatest returns. We believe a commodity super-cycle is underway that...
News
Investment thesis Our current investment thesis is: Jill’s growth has been underwhelming, as its niche demographic and competitive pressures have impeded the company’s progress....
News
Ares Commercial Real Estate Corporation (NYSE:ACRE) is a commercial real estate investment trust with a large portfolio of senior commercial mortgage loans. Though the...
News
Digital marketing agency network S4 Capital (OTCPK:SCPPF) is one of my worst-performing holdings at the moment and has been a crushing disappointment to me....
News
With all the discussion and coverage of artificial intelligence, one might think the data, the understanding, the concerns were all understood and available to...
News
Investment thesis We view Kyowa Kirin (OTCPK:KYKOF) shares as being a cheap option on the positive outcome for the atopic dermatitis (eczema) drug currently...
